Leung Kam
National Center for Biotechnology Information, NLM, NIH, Bethesda, MD
Malignant melanoma is the deadliest form of skin cancer (1). Early and accurate diagnosis is necessary for surgery and successful treatment (2). The melanocortin (MC) system is a neuropeptide network of the skin, and it is involved in pigmentation regulation, cortisol production, and many other physiological processes (3). Most cutaneous cell types express MC receptors, proopiomelanocortin (POMC), and prohormone convertases, and they also release MCs. However, these receptors have been found to be overexpressed in melanoma cells. There are five MC receptors (MC1R to MC5R), which belong to the G-protein−coupled receptor superfamily. Melanotropin-stimulating hormones (α-, β-, and γ-MSH) are derived from POMC by the proteolytic action of prohormone convertases. α-MSH (Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH), produced by the brain and pituitary gland, is a tridecapeptide (13 amino acids) and is the most potent melanotropic peptide (4) in the regulation of skin pigmentation MC1R. Although positron emission tomography (PET) imaging with [F]fluoro-2-deoxy-2-d-glucose ([F]FDG) is effective in the detection of melanoma, it is not melanoma-specific and some melanoma cells do not take up [F]FDG (5, 6). [F]FDG has been approved for cancer imaging by the United States Food and Drug Administration. Radiolabeled α-MSH peptide analogs have been shown to specifically bind to MC1R that is overexpressed on human and mouse melanoma cells (5, 7-10). 1,4,7,10-Tetraazacyclododecane-,,,-tetraacetic acid (DOTA) has been successfully coupled to the α-MSH peptide analogs for radiolabeling with a variety of radionuclides (5). A lactam bridge-cyclized α-MSH analog, GlyGlu-c[Lys-Nlc-Glu-His-d-Phe-Arg-Trp-Gly-Arg-Pro-Val-Asp] (GlyGlu-CycMSH), was conjugated with DOTA (11). DOTA-GlyGlu-CycMSH was radiolabeled with Ga as a potential molecular imaging agent to target melanoma (12). Ga is a positron emitter with a physical half-life of 3.3 d and is suitable for single-photon emission computed tomography (SPECT) imaging.
恶性黑色素瘤是最致命的皮肤癌形式(1)。早期准确诊断对于手术和成功治疗至关重要(2)。黑皮质素(MC)系统是皮肤的一种神经肽网络,参与色素沉着调节、皮质醇生成及许多其他生理过程(3)。大多数皮肤细胞类型表达MC受体、阿片促黑皮质素原(POMC)和激素原转化酶,并且它们也释放MC。然而,已发现这些受体在黑色素瘤细胞中过表达。有五种MC受体(MC1R至MC5R),它们属于G蛋白偶联受体超家族。促黑素激素(α-、β-和γ-MSH)由激素原转化酶的蛋白水解作用从POMC衍生而来。由脑和垂体产生的α-MSH(Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH)是一种十三肽(13个氨基酸),是调节皮肤色素沉着MC1R中最有效的促黑素肽(4)。尽管用[F]氟-2-脱氧-2-D-葡萄糖([F]FDG)进行正电子发射断层扫描(PET)成像在检测黑色素瘤方面有效,但它并非黑色素瘤特异性的,且一些黑色素瘤细胞不摄取[F]FDG(5,6)。[F]FDG已被美国食品药品监督管理局批准用于癌症成像。放射性标记的α-MSH肽类似物已显示能特异性结合在人和小鼠黑色素瘤细胞上过度表达的MC1R(5,7 - 10)。1,4,7,10-四氮杂环十二烷-N,N',N'',N'''-四乙酸(DOTA)已成功与α-MSH肽类似物偶联,用于用多种放射性核素进行放射性标记(5)。一种内酰胺桥环化的α-MSH类似物,甘氨酰谷氨酸-c[赖氨酸-Nlc-谷氨酸-组氨酸-d-苯丙氨酸-精氨酸-色氨酸-甘氨酸-精氨酸-脯氨酸-缬氨酸-天冬氨酸](甘氨酰谷氨酸-CycMSH)与DOTA偶联(11)。DOTA-甘氨酰谷氨酸-CycMSH用镓进行放射性标记,作为一种潜在的靶向黑色素瘤的分子成像剂(12)。镓是一种正电子发射体,物理半衰期为3.3天,适用于单光子发射计算机断层扫描(SPECT)成像。